Michael Thomas Bestawros

Michael Bestawros practices at Lovelace Medical Center in Albuquerque, New Mexico, part of Ardent Health.

Michael Bestawros' NPI, 1699909879, was assigned on May 4, 2009. Michael Bestawros graduated from Emory School of Medicine in 2005. Michael Bestawros holds New Mexico license MD2014-0521.

Michael Bestawros' primary practice is Lovelace Medical Center, at 601 Dr Martin Luther King Jr Ave NE, Albuquerque, NM 87102 in Bernalillo County. The practice phone is (505) 727-8000.

Michael Bestawros' primary practice is Lovelace Medical Center in Albuquerque, New Mexico, part of Ardent Health. Michael Bestawros is also affiliated with Presbyterian Hospital. The medical group on file is Lovelace Medical Group. Dmand AI also links Michael Bestawros to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Bestawros practices, 7 sites in all. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Michael Bestawros' primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Michael Bestawros is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Michael Bestawros' licenses on file in 3 states: New Mexico, Tennessee and North Carolina.

Dmand AI lists atrial fibrillation and flutter, cardiac arrhythmia, heart blockage, intermittent racing heartbeat (PSVT), pacemaker or defibrillator implantation, pacemaker replacement, sick sinus syndrome and ventricular tachycardia among the conditions Michael Bestawros treats.

CMS data shows 6,376 Medicare services from Michael Bestawros across 28 procedure codes in 2024, for 3,287 Medicare patients. Medicare paid $260,269 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 3,287 Medicare patients who saw Michael Bestawros in 2024. The largest group is 75 to 84, with 1,325 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Bestawros' median patient age at 78, with 48% women.

In 2024, Michael Bestawros wrote 1,764 Medicare Part D claims for 391 patients. 66% of them were for generic drugs. CMS names the drug for 1,636 of them, across 21 drugs with 11 or more claims each, at $675,856 in total drug cost. In 2023, CMS named 1,506 claims across 20 drugs.

Michael Bestawros accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Bestawros as offering telehealth. CMS counts 48 procedures of pacemaker insertion or repair by Michael Bestawros, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Michael Bestawros, published from 2014 to 2016. 2014 was the busiest year, with 3. Michael Bestawros' most frequent co-authors are Ashley Lauren Canipe, John Robert Koethe, MD and Satish Raj, MD.

Dmand AI links Michael Bestawros to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Atrial Fibrillation, Arrhythmias, Cardiac and Hemorrhage. AtriCure, Inc. sponsors the most, 2.

CMS Open Payments shows 638 general payments to Michael Bestawros from 29 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Medical Device Business Services, Inc. paid the most, $58,377.

Michael Bestawros graduated from Emory School of Medicine in 2005.

Michael Bestawros is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.